abacusdiagnostica 产品代理
abacusdiagnostica 产品代理
我们的公司位于芬兰西南海岸的图尔库市的动态科学园区，重点关注生命科学。
Abacus的愿景是提供经济高效且易于使用的产品，以便在资源和能力有限的环境下实现分子诊断。我们的解决方案能够在不影响结果质量的情况下实现常规分子诊断，并将分子诊断提升到更简单的水平。客户需求是我们每一步的核心价值。
珠算诊断学于2004由图尔库大学生物技术系的GeimaLea-技术发明者创立。我们目前正在开发新技术，并扩大GenomEra®CDX分析平台的分析选择，该平台旨在识别流感、艰难梭菌、MRSA等传染病以及其他关键人类病原体和抗生素耐药性标记。
GENOMERA® CDX SYSTEM
NOROVIRUS
FLU A/B + RSV
SARS-COV-2
SARS-COV-2, FLU A/B + RSV
RUO SARS-COV-2 + VOC
MRSA/SA AC
MRSA/SA MULTI SWAB
C. DIFFICILE
GBS (GROUP B STREPTOCOCCUS)
Abacus Diagnostica Oy is a Finnish molecular diagnostics company specialized in rapid molecular testing utilizing the patented GenomEra® -technology.
Our company is located in the dynamic Science Park area with a strong focus in life sciences in the city of Turku at the Southwest coast of Finland.
Abacus’ vision is to provide cost-effective and easy-to-use products to enable molecular diagnostics also in resource and capability limited settings. Our solutions enables routine molecular diagnostics without compromising the quality of results and move the molecular diagnostics to the next level of simplicity. Customers’ needs is our core value with every single step.
Abacus Diagnostica Oy was founded in 2004 by the inventors of the GenomEra® -technology at the Department of Biotechnology at the University of Turku. We are currently developing new technologies and expanding assay selection for the GenomEra® CDX assay platform, intended for the identification of infectious diseases like Influenza, C. difficile, MRSA and other critical human pathogens and antibiotic resistance markers.
